$1.40's after hours. I think it recovers in a big way tomorrow. Needed today after yesterday's take off. 20-25m OS and a $1.50 PPS values this biotech at only $37 million. Deal with Bayer alone should see this move to 10x that for starters in 2020. Great long term hold imo.
Insane looking at this:
Under the agreement, Daré will receive an upfront payment and access to Bayer's extensive clinical and market capabilities while retaining control over Ovaprene's development and regulatory approval process. Bayer receives the right to obtain exclusive rights to commercialize the product in the U.S. following completion of the pivotal clinical trial being undertaken by Daré. If Bayer, in its sole discretion, makes payment to Daré of $20 million, which Daré intends to apply to reimbursement of clinical study costs, then the exclusive license to commercialize Ovaprene in the U.S. will become effective. Daré will also be entitled to receive commercial milestone payments potentially totaling $310 million, in addition to double digit tiered royalties on net sales.
News 
Market Data 
Discover 
